ReviewJCO global oncology2020

Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population.

Ahmed Badran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.